NCT07033871

Brief Summary

With the continuous development of China's economy and the improvement of medical standards, the life expectancy of the Chinese population has significantly increased. Against the backdrop of accelerating aging in China, the incidence of age-related chronic non-communicable diseases (NCDs), such as cardiovascular and cerebrovascular diseases and chronic respiratory diseases, has risen remarkably. These diseases are characterized by multiple comorbidities, high disability rates, and high mortality rates, severely compromising the quality of life of older adults, exacerbating family burdens, and straining healthcare systems. This constitutes one of the major challenges faced by aging societies. Therefore, early detection and intervention of chronic diseases in older adults are critical measures to address population aging. Comprehensive geriatric assessment (CGA), a core specialty of geriatric medicine, serves as a fundamental framework for the clinical identification of geriatric syndromes and multidisciplinary management. It is emerging as a key pathway to promote "healthy aging." Guided by this premise, this study aims to explore the application value of CGA in managing chronic diseases among older adults, with the goal of achieving full-cycle management for early detection, diagnosis, and treatment of chronic conditions in China's elderly population.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
49mo left

Started Jul 2025

Longer than P75 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress18%
Jul 2025May 2030

First Submitted

Initial submission to the registry

May 26, 2025

Completed
29 days until next milestone

First Posted

Study publicly available on registry

June 24, 2025

Completed
7 days until next milestone

Study Start

First participant enrolled

July 1, 2025

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2030

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2030

Last Updated

June 24, 2025

Status Verified

May 1, 2025

Enrollment Period

4.8 years

First QC Date

May 26, 2025

Last Update Submit

June 14, 2025

Conditions

Keywords

Comprehensive Geriatric AssessmentChronic Disease ManagementOlder Adults

Outcome Measures

Primary Outcomes (1)

  • Major adverse events (MAE)

    Major adverse events (MAE) in overall population, defined as composite of all-cause death, Heart Failure hospitalization, recurrent myocardial infarction, stroke, etc.

    These data is collected during follow-up visit at 3/6/12/24/36 months after discharge

Other Outcomes (33)

  • Age for each participant

    These data is collected from the cases' medical record in an average of 1 month after the sample recruiting

  • Gender for each participant

    These data is collected from the cases' medical record in an average of 1 month after the sample recruiting

  • Height for each participant

    These data is collected from the cases' medical record in an average of 1 month after the sample recruiting

  • +30 more other outcomes

Study Arms (2)

Elderly patients with chronic diseases

The study population consisted of patients with chronic diseases in the elderly who underwent comprehensive geriatric assessment and management. Chronic diseases in the elderly included but were not limited to chronic heart failure, chronic obstructive pulmonary disease, cognitive dysfunction, and so on. We compared various biochemical indexes, cardiac function indexes, quality of life, and the occurrence of long-term adverse events before and after the comprehensive geriatric assessment and management.

Diagnostic Test: comprehensive geriatric assessment

Healthy elderly population

The control group was composed of elderly subjects without evidence of chronic diseases. Chronic diseases was excluded by performing a complete medical history, a comprehensive physical examination, and an echocardiogram.

Diagnostic Test: comprehensive geriatric assessment

Interventions

The comprehensive geriatric assessment (CGA) is a multi dimensional diagnostic process used to determine the medi cal, psychological, and functional capabilities of a frail elderly person to develop a coordinated and integrated plan for treat ment and long-term follow-up.

Elderly patients with chronic diseasesHealthy elderly population

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population consisted of patients with chronic diseases in the elderly who underwent comprehensive geriatric assessment and management. Chronic diseases in the elderly included but were not limited to chronic heart failure, chronic obstructive pulmonary disease, cognitive dysfunction, and so on.

You may qualify if:

  • \. Aged 60 years or older 2. Diagnosed with chronic diseases in the circulatory, respiratory, digestive, nervous, or endocrine systems, consistent with corresponding disease diagnostic criteria; 3. Availability of complete medical records; 4. Clear consciousness and ability to independently answer questions; 5. Signed informed consent form.

You may not qualify if:

  • \. Presence of any condition/circumstance which in the opinion of the investigator could significantly limit the complete follow up of the patient (e.g. tourist, non-native speaker or does not understand the local language, psychiatric disturbances).
  • \. Presence of serious/severe co-morbidities in the opinion of the investigator which may limit short term (i.e. 6 month) life expectancy.
  • \. Current participation in a randomised interventional clinical trial.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Central Study Contacts

Yang Xinying Yang Xinying

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
5 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 26, 2025

First Posted

June 24, 2025

Study Start

July 1, 2025

Primary Completion (Estimated)

May 1, 2030

Study Completion (Estimated)

May 1, 2030

Last Updated

June 24, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share